发明名称 Osteoclast inhibitors such as zoledronic acid for low back pain treatment
摘要 Methods for the safe administration of imidazole or imidazolium compounds, and conditions that may be treated by these methods, are described herein.
申请公布号 US9289441(B2) 申请公布日期 2016.03.22
申请号 US201514639013 申请日期 2015.03.04
申请人 ANTECIP BIOVENTURES II LLC 发明人 Tabuteau Herriot;Karppinen Jaro I.
分类号 A61K31/66;A61K31/675;A61K31/663 主分类号 A61K31/66
代理机构 K&L Gates LLP 代理人 K&L Gates LLP ;Cullman Louis C.;Johnson Brent A.
主权项 1. A method of treating Modic changes type I, comprising administering an osteoclast inhibitor to a mammal in need thereof, wherein the mammal experiences pain relief three months after the osteoclast inhibitor is administered; and wherein the osteoclast inhibitor is risedronic acid, cimadronic acid, or etidronic acid.
地址 New York NY US